Epic Now Fully Supports USCDI Version 3
Newest version of United States Core Data for Interoperability standard adds data elements including tribal affiliation, disability status, caregiver relationships, and preferred language
Read More
Journalists Evaluate Rural Voter Sentiment, MAHA Movement, and Gene-Editing Finding
KFF Health News chief rural correspondent Sarah Jane Tribble discussed the findings of a KFF-Associated Press poll about rural support for the Make America Healthy Again movement on NPR’s Morning Edition on Sept. 30. Click here to hear Tribble on Morning Edition. Read Tribble’s “Rural MAHA Followers Say Trump Health Policies Haven’t Reached Their Communities,”…
Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer
Solu Therapeutics’ platform technology, which was licensed from GSK, pairs a small molecule with an antibody to address elusive disease targets. Cancer is Solu’s initial focus, but the startup is also exploring applications of its platform to immunology. The post Solu Therapeutics Lands $41M for Clinical Test of Novel Antibody Drug for Blood Cancer appeared…
Why Your Patients Are Leaving and How to Stop It
[Sponsored] Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust. The post Why Your Patients Are Leaving and How to Stop It appeared first on MedCity News.
Medicare Advantage in 2025: Enrollment Update and Key Trends
In 2025, more than half (54%) of eligible Medicare beneficiaries are enrolled in Medicare Advantage plans. This brief provides current information about Medicare Advantage enrollment, by plan type and firm, and shows how enrollment varies by state and county.
GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years
President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years…
Healthcare AI: What’s in your chatbot?
By OWEN TRIPP So much of the early energy around generative AI in healthcare has been geared toward speed and efficiency: freeing doctors from admin tasks, automating patient intake, streamlining paperwork-heavy pain points. This is all necessary and helpful, but much of it boils down to established players optimizing the existing system to suit their…
How Wearables Are Changing the Way We Monitor Cancer Treatment
This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources. The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared…
Teledoc Medication Abortions Under Attack
By MIKE MAGEE For those prepared to take a deep breath and relax in the aftermath of the MAGA induced assault on the First Amendment that whipsawed Disney leadership last week as they abandoned and then rescued Jimmy Kimmel, be advised reproductive health access is at the top of the list when it comes to…
Medicaid 1115 Waiver Watch: Round-up of Key Themes at the End of the Biden Administration
Section 1115 Medicaid demonstration waivers offer states an avenue to test new approaches in Medicaid that differ from what is required by federal statute, so long as the approach is likely to “promote the objectives of the Medicaid program.” Waivers generally reflect priorities identified by states as well as changing priorities from one presidential administration…